Driehaus Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $6.31M | Sell |
|
|||||
|
2024
Q1 | $6.42M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $9.96M | Sell |
|
|||||
|
2023
Q2 | $9.32M | Buy |
|
|||||
|
2023
Q1 | $7.98M | Buy |
|
|||||
|
2022
Q4 | $6.84M | Buy |
|
|||||
|
2022
Q3 | $7.68M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $950K | Buy |
|